×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
HBIO – harvard bioscience, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
HBIO
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
3/3
07:30 am
hbio
Harvard Bioscience to Participate in KeyBanc’s Virtual Healthcare Forum
Medium
Report
Harvard Bioscience to Participate in KeyBanc’s Virtual Healthcare Forum
2/26
07:30 am
hbio
Harvard Bioscience Schedules Fourth Quarter 2025 Earnings Conference Call for March 12, 2026 at 8:00 AM ET
Low
Report
Harvard Bioscience Schedules Fourth Quarter 2025 Earnings Conference Call for March 12, 2026 at 8:00 AM ET
2/10
07:30 am
hbio
Harvard Bioscience Announces Preliminary Fourth Quarter Financial Results, Positive Outlook for 2026 & Outlines Long-Term Strategic Focus Areas
Medium
Report
Harvard Bioscience Announces Preliminary Fourth Quarter Financial Results, Positive Outlook for 2026 & Outlines Long-Term Strategic Focus Areas
1/29
07:04 pm
hbio
Harvard Bioscience Announces Strategic Consolidation of Manufacturing Operations to Improve Efficiency and Support Long-Term Growth [Yahoo! Finance]
Medium
Report
Harvard Bioscience Announces Strategic Consolidation of Manufacturing Operations to Improve Efficiency and Support Long-Term Growth [Yahoo! Finance]
1/29
04:30 pm
hbio
Harvard Bioscience Announces Strategic Consolidation of Manufacturing Operations to Improve Efficiency and Support Long-Term Growth
Medium
Report
Harvard Bioscience Announces Strategic Consolidation of Manufacturing Operations to Improve Efficiency and Support Long-Term Growth
12/17
07:30 am
hbio
Harvard Bioscience Announces the Successful Completion of Debt Refinancing with Comprehensive Growth Financing Package
High
Report
Harvard Bioscience Announces the Successful Completion of Debt Refinancing with Comprehensive Growth Financing Package
12/13
07:50 am
hbio
Harvard Bioscience (NASDAQ:HBIO) was upgraded by analysts at Zacks Research to a "hold" rating.
Low
Report
Harvard Bioscience (NASDAQ:HBIO) was upgraded by analysts at Zacks Research to a "hold" rating.
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
2/12
11:27 am
hbio
Form SCHEDULE 13G/A HARVARD BIOSCIENCE INC Filed by: Leviticus Partners LP
Medium
Report
Form SCHEDULE 13G/A HARVARD BIOSCIENCE INC Filed by: Leviticus Partners LP
2/10
07:30 am
hbio
Form 8-K HARVARD BIOSCIENCE INC For: Feb 10
Medium
Report
Form 8-K HARVARD BIOSCIENCE INC For: Feb 10
2/10
06:05 am
hbio
Form EFFECT HARVARD BIOSCIENCE INC
High
Report
Form EFFECT HARVARD BIOSCIENCE INC
2/9
04:03 pm
hbio
Form 424B3 HARVARD BIOSCIENCE INC
High
Report
Form 424B3 HARVARD BIOSCIENCE INC
1/30
05:15 pm
hbio
Form DEF 14A HARVARD BIOSCIENCE INC For: Mar 06
Low
Report
Form DEF 14A HARVARD BIOSCIENCE INC For: Mar 06
1/30
05:02 pm
hbio
Form S-3 HARVARD BIOSCIENCE INC
Low
Report
Form S-3 HARVARD BIOSCIENCE INC
1/29
04:31 pm
hbio
Form 8-K HARVARD BIOSCIENCE INC For: Jan 23
High
Report
Form 8-K HARVARD BIOSCIENCE INC For: Jan 23
1/20
05:05 pm
hbio
Form PRE 14A HARVARD BIOSCIENCE INC For: Jan 20
Low
Report
Form PRE 14A HARVARD BIOSCIENCE INC For: Jan 20
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
7/25
Form 8-K HARVARD BIOSCIENCE INC For: Jul 25
45.9%
3/23 Harvard Bioscience Introduces Next Generation Inhalation System to Aid in the Fight Against COVID-19 14.0%
2/26 Form 8-K HARVARD BIOSCIENCE INC For: Feb 26 13.8%
2/27 Harvard Bioscience, Inc. (NASDAQ: HBIO) had its price target raised by analysts at Benchmark Co. from $3.50 to $4.00. They now have a "speculative buy" rating on the stock. 13.1%
11/13 Form 4 HARVARD BIOSCIENCE INC For: Nov 11 Filed by: Green James W 12.2%
9/9 Harvard Bioscience Announces Strategic Action Plan and Financial Targets 10.4%
8/20 Form 4 HARVARD BIOSCIENCE INC For: Aug 20 Filed by: Loewald Thomas W 10.4%
7/18 Harvard Bioscience Names Michael Rossi Chief Financial Officer 9.6%
12/23 Form 8-K HARVARD BIOSCIENCE INC For: Dec 17 6.6%
4/8 Form 3 HARVARD BIOSCIENCE INC For: Apr 06 Filed by: Steele Susan M. 6.4%
3/23 Harvard Bioscience Introduces Next Generation Inhalation System to Aid in the Fight Against COVID-19 14.0%
2/26 Form 8-K HARVARD BIOSCIENCE INC For: Feb 26 13.8%
2/27 Harvard Bioscience, Inc. (NASDAQ: HBIO) had its price target raised by analysts at Benchmark Co. from $3.50 to $4.00. They now have a "speculative buy" rating on the stock. 13.1%
11/13 Form 4 HARVARD BIOSCIENCE INC For: Nov 11 Filed by: Green James W 12.2%
9/9 Harvard Bioscience Announces Strategic Action Plan and Financial Targets 10.4%
8/20 Form 4 HARVARD BIOSCIENCE INC For: Aug 20 Filed by: Loewald Thomas W 10.4%
7/18 Harvard Bioscience Names Michael Rossi Chief Financial Officer 9.6%
12/23 Form 8-K HARVARD BIOSCIENCE INC For: Dec 17 6.6%
4/8 Form 3 HARVARD BIOSCIENCE INC For: Apr 06 Filed by: Steele Susan M. 6.4%
TOP News Decliners
7/8
Form 8-K HARVARD BIOSCIENCE INC For: Jul 02
-16.3%
5/8 Form 8-K HARVARD BIOSCIENCE INC For: May 08 -10.9%
7/27 Harvard Bioscience, Inc. (NASDAQ: HBIO) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $2.00 price target on the stock. -10.1%
11/5 Q3/2019 9/30/2019 EPS 0.040 ZacksConsensus 0.030 ActVsEst 0.010 - Beat -8.5%
8/1 Form 4 HARVARD BIOSCIENCE INC For: Aug 01 Filed by: Eade Katherine A. -8.2%
3/16 Form 10-K HARVARD BIOSCIENCE INC For: Dec 31 -7.7%
4/23 Harvard Bioscience Schedules First Quarter 2020 Earnings Conference Call for May 5, 2020 at 8:00 AM ET -7.3%
11/8 Form 10-Q HARVARD BIOSCIENCE INC For: Sep 30 -5.8%
7/3 Form SC 13G/A HARVARD BIOSCIENCE INC Filed by: First Light Asset Management, LLC -5.0%
3/3 Harvard Bioscience, Inc. (NASDAQ: HBIO) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $3.75 price target on the stock. -4.5%
5/8 Form 8-K HARVARD BIOSCIENCE INC For: May 08 -10.9%
7/27 Harvard Bioscience, Inc. (NASDAQ: HBIO) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $2.00 price target on the stock. -10.1%
11/5 Q3/2019 9/30/2019 EPS 0.040 ZacksConsensus 0.030 ActVsEst 0.010 - Beat -8.5%
8/1 Form 4 HARVARD BIOSCIENCE INC For: Aug 01 Filed by: Eade Katherine A. -8.2%
3/16 Form 10-K HARVARD BIOSCIENCE INC For: Dec 31 -7.7%
4/23 Harvard Bioscience Schedules First Quarter 2020 Earnings Conference Call for May 5, 2020 at 8:00 AM ET -7.3%
11/8 Form 10-Q HARVARD BIOSCIENCE INC For: Sep 30 -5.8%
7/3 Form SC 13G/A HARVARD BIOSCIENCE INC Filed by: First Light Asset Management, LLC -5.0%
3/3 Harvard Bioscience, Inc. (NASDAQ: HBIO) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $3.75 price target on the stock. -4.5%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: